Akums Drugs & Pharmaceuticals Ltd. has recently forged a collaboration with LC Ingredients to procure the raw material, manufacture, innovate and sell finished products containing Cynatine to all Indian big pharmaceutical and nutraceutical companies.
According to experts, deficiency of the fibrous protein called keratin in hair and nails results in an increase in hair loss, thin and grey hair, as well as easily breakable and discolored fingernails. However, Cynatine’s high bioavailability makes it capable of delivering keratin peptides to the body and can be consumed by humans, with no fear of toxicity associated with it, the company claims.
Meanwhile, Sandeep Jain, Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, said that Akums is now the only company in India with exclusive rights to sell this supplement.
“Even though Cynatine is a soluble form of Keratin, it has not yet been listed with the regulatory authority FSSAI; means that no pharmaceutical company in India is permitted to produce it. This makes Akums, the only company in India with exclusive rights to sell this supplement. We have already conducted our own clinical trials on the Indian population and classified the supplement within the normal foods category. Cynatine reduces hair loss, boosts hair strength, and enhances hair’s radiance and shine. It helps to promote firmness and elasticity in the skin, minimizes fine lines and wrinkles, and improves strength by binding to the nail. And we are extremely excited to market it so that the Indian consumers may benefit from using it too,” Jain said.
Discussion about this post